Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 147.4 M177.8 M— — Research & development 42 M38.8 M— — Operating income 58.9 M52 M-1.54 B — Non-Operating Income, Total 0500 K-1.1 M — Interest expense, net of interest capitalized —16.3 M— — Non-Operating Income, excl. Interest Expenses 0-16.3 M-1.1 M — Unusual income/expense 0500 K— — Pretax income 58.9 M35.2 M1.22 B — Equity in earnings ——— — Taxes 11.3 M4.7 M333.9 M — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations 47.6 M39.9 M1.07 B — Discontinued operations ——— — Net income 47.6 M39.9 M1.07 B — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 47.6 M39.9 M1.07 B — Basic earnings per share (Basic EPS) 0.420.35— — Diluted earnings per share (Diluted EPS) 0.420.359.5 — Average basic shares outstanding 112.7 M112.8 M112.8 M — Diluted shares outstanding 112.7 M113.4 M112.8 M — EBITDA 87.5 M82 M— — EBIT 58.9 M52 M— — Cost of revenue 255 M260.5 M— — Other cost of goods sold ——— — Depreciation & amortization (cash flow) 28.6 M30 M86.9 M —